Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Technology General Corp. Makes Announcement.


ISELIN, N.J.--(BUSINESS WIRE)--Nov. 24, 1999--

Bio-Technology General Corp. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:BTGC BTGC Bio-Technology General (stock symbol)
BTGC Bukit Tinggi Golf Club (Malaysia) 
) today announced that Eli Admoni, President of Bio-Technology General (Israel) Ltd., BTG's Israeli subsidiary, and a Senior Vice President of BTG BTG BIT (Built-In Test) Target Generator
BTG Bridging the Gap
BTG British Technology Group
BtG Betreuungsgesetz (Germany)
BTG Biomass Technology Group BV
BTG Begbies Traynor Group
, has decided to leave BTG to pursue other business opportunities.

Sim (1) (Society for Information Management, Chicago, IL, www.simnet.org) Founded in 1968 as the Society for MIS, it is a membership organization made up of corporate and division heads of IT organizations.  Fass, BTG's Chairman and Chief Executive Officer, stated: "We thank Eli for his hard work during the short period he was with us, and wish him well in his future endeavors."

Bio-Technology General Corp., a leading biopharmaceutical company, develops, manufactures and markets genetically engineered genetically engineered adjective Recombinant, see there  and other products for human health care. The Company's products are marketed in over thirty countries worldwide.

Statements in this news release concerning the Company's business outlook or future economic performance, anticipated profitability, revenues, expenses or other financial items; and statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are "forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
" as that term is defined under the Federal Securities Laws. Forward-looking statements are subject to risks, uncertainties and other factors which could cause actual results to differ materially from those stated in such statements. Such risks, uncertainties and factors include, but are not limited to, changes and delays in product development plans and schedules, customer acceptance of new products, changes in pricing or other actions by competitors, patents owned by the Company and its competitors, and general economic conditions, as well as other risks detailed in the Company's filings with the Securities and Exchange Commission.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 24, 1999
Words:243
Previous Article:3Com Racks Up a Full House With Five Awards At Comdex 99; Industry-Leading Connectivity Solutions Garner Three PC Computing MVP Awards and Two PC...
Next Article:Aunt Myra's Inc. Subsidiary, One E Group Inc. Announces Board Appointments.
Topics:



Related Articles
Bio-Technology General Promotes General Counsel, Robert M. Shaw, Esq., to Senior Vice President.
Teva Pharmaceutical Industries Ltd. and Bio-Technology General Corp. Announce Strategic Alliance in the Development and Worldwide Commercialization...
Bio-Technology General Corp. and Teva Pharmaceutical Industries Ltd. Announce Strategic Alliance in the Development and the Worldwide...
Teva Pharmaceutical Industries Ltd. to Market BTG's Human Growth Hormone In The United States.
Bio-Technology General Corp. Announces February 22 Webcast Discussion of Earnings and the Company's Business.
ASSOCIATION NEWS.
Bio-Technology General Corp. Announces July 24 Webcast Discussion of Earnings and the Company's Business.
Biotech cluster in the offing.
Iogen Corp.
Takara Bio Grants Transgenomic License for LA-PCR Technology.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles